April 16, 2021

In This Issue
Maine Medical Association Statement on Johnson & Johnson COVID-19 Vaccine Pause
FDA Update & Statement on Johnson & Johnson COVID-19 Vaccine Pause Recommendation
Thrombotic Thrombocytopenia & J&J COVID Vaccine Response from the Manufacturer
Over 30 Percent of US Adults Fully Vaccinated, Maine Leads the Nation
Maine CDC COVID-19 Update for Clinicians with Stephen Sears, MD
Clinical Updates and Guidance Related to COVID-19
Medicare FFS Claims: 2% Payment Adjustment (Sequestration) Suspended Through December
MaineCare Updates: Upcoming Accountable Communities Public Webinar & Primary Care 2.0 Presentation Available Online
HealthCare Dive: Urgent Care Centers Draw Some ER Visits but Associated with Higher Spending Overall
Webinar for Medical Students April 22: So You Are Employed, Now What?
Next MMA Legislative Call Will Be Wednesday, April 21st
Maine Community Action Partnership is Working for a Successful Vaccine Roll Out for All
Maine Medical Association & ActionPPE Partner Again; This Time for FDA Approved Rapid Antigen Tests
A Message from Maine Responds: Volunteer Opportunity
Maine Legislature Week 14 Update
Maine Legislature Public Hearings, Work Sessions & New Bills
Upcoming Specialty Society Meetings
Maine CDC Physicians To Host Regular Clinician COVID Vaccine Info Sessions
"Prescribing to Reduce Opioid Overdose Risk: How to Impact the Epidemic Within the Pandemic"
NAMI Maine Workshops in May & June: Suicide Prevention & Management for Clinical Staff
AAP EQIPP Course: Immunizations - Strategies for Success (for RURAL Health Providers)
New Maine AAP Educational Webinar Series
Nurse Practitioner
Executive Director
Medical Director - ME License Required
Practice Administrator
Psychiatric Nurse Practitioner

Search Back Issues







Follow Us:
Maine Medical Association Statement on Johnson & Johnson COVID-19 Vaccine Pause


The MMA released the following media statement shortly after Tuesday’s US FDA recommendation, and Governor Mills’ call the pause administration of the Johnson & Johnson COVID vaccine.

News: For Immediate Release

Additional Information Contact: 

Dan Morin, Director of Communications & Government Affairs 

(207) 838-8613 – mobile 



MANCHESTER, (April 13, 2021) --- Today, the US Food and Drug Administration and Centers for Disease Control and Prevention recommended a pause in the use of the coronavirus vaccine developed by Johnson & Johnson out of an abundance of caution after six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. 

Shortly after, the Maine Center for Disease Control and Prevention announced they were not aware of any reports of these cases in Maine residents. Given this recommendation, the State of Maine is also advising that providers pause administration of the Johnson & Johnson vaccine until the U.S. CDC’s scientific advisory committee has further reviewed the safety data. 

MMA President, Karen Saylor, M.D., applauded the move but cautioned, “The reported events are extremely rare, and it has not yet been proven that the vaccine caused the reported blood clots.” She added, “Pausing administration of J&J doses is the right move as all safety concerns should be investigated immediately and thoroughly. This shows our regulatory agencies are doing their job and placing safety first.” 

About the Maine Medical Association:

The MMA was founded in 1853 and represents all of Maine's physicians, residents & medical students across all clinical specialties, organizations, and practice settings. 



Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm

Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©